Basic Information
| LncRNA/CircRNA Name | SEMA3B-AS1 |
| Synonyms | NA |
| Region | GRCh38_3:50266641-50267371 |
| Ensemble | ENSG00000232352 |
| Refseq | NR_110702 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot |
| Sample | SNU-398 and SNU-182 HCC cell lines, liver biopsy 73 to collect cancer (HCC) and adjacent (2 cm around tumors) non-cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | SEMA3B-AS1 was downregulated in 17 HCC tissues comparing to non-cancer tissues and was not affected by HBV and HCV 18 infections. In addition, SEMA3B-AS1 expression was not affect by cancer 19 development and low SEMA3B-AS1 levels were closely correlated with poor 20 survival. SEMA3B-AS1 in HCC tissues was inversely correlated with miR-718 and 21 positively correlated with PTEN. In HCC cells, SEMA3B-AS1 overexpression 22 resulted in upregulated, while miR-718 overexpression resulted in downregulated 23 PTEN expression. In addition, miR-718 overexpression attenuated the effects of 24 SEMA3B-AS1 overexpression. SEMA3B-AS1 and PTEN overexpression resulted in 25 reduced, while miR-718 overexpression resulted in increased proliferation rate of 26 HCC cells. In addition, miR-718 overexpression attenuated the effects of SEMA3B27 AS1 overexpression. |
| Pubmed ID | 31251699 |
| Year | 2019 |
| Title | MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and 2 PTEN to regulate the proliferation of hepatocellular carcinoma cells |
External Links
| Links for SEMA3B-AS1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |